Source: Molecular Pharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, CANAIS IÔNICOS, ACETILCOLINA, RECEPTORES DE ACETILCOLINA
ABNT
SHAW, K. P. et al. Reversible cholinesterase inhibition physostigmine has channel-blocking and agonist effects on the acetylcholine receptor ion channel complex. Molecular Pharmacology, v. 28, p. 527-538, 1985Tradução . . Acesso em: 15 out. 2024.APA
Shaw, K. P., Aracava, Y., Akaike, A., Dely, J. W., Rickett, D. L., & Albuquerque, E. X. (1985). Reversible cholinesterase inhibition physostigmine has channel-blocking and agonist effects on the acetylcholine receptor ion channel complex. Molecular Pharmacology, 28, 527-538.NLM
Shaw KP, Aracava Y, Akaike A, Dely JW, Rickett DL, Albuquerque EX. Reversible cholinesterase inhibition physostigmine has channel-blocking and agonist effects on the acetylcholine receptor ion channel complex. Molecular Pharmacology. 1985 ; 28 527-538.[citado 2024 out. 15 ]Vancouver
Shaw KP, Aracava Y, Akaike A, Dely JW, Rickett DL, Albuquerque EX. Reversible cholinesterase inhibition physostigmine has channel-blocking and agonist effects on the acetylcholine receptor ion channel complex. Molecular Pharmacology. 1985 ; 28 527-538.[citado 2024 out. 15 ]